Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
about
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinomaIntegrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma.Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaUpdate on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics DatabasePerioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy.Cholangiocellular Carcinoma.Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas?Epidemiology and Risk Factors of Cholangiocarcinoma.Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management.Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.Cholangiocarcinoma - evolving concepts and therapeutic strategies.Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.Including the Sheath Rinse to Improve Cellular Yield in Biliary Brushing Cytology.Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma via activating Akt/NF-κB signaling by paracrine CCL5.An Unusual Presentation of Advanced Intrahepatic Cholangiocarcinoma: When Biopsy Results Fail.Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma.Cholangiocarcinoma‑associated genes identified by integrative analysis of gene expression data.Upper gastrointestinal malignancies in 2017: current perspectives and future approaches.miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.Immune checkpoint therapy in liver cancer.Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging.Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case reportIntegrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular ProfilesResection for Klatskin tumors: technical complexities and resultsInhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of Akt pathwayCohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma
P2860
Q28076535-2E2BF1AD-3038-433D-AE51-2112F94E8149Q32173000-490025ED-FAD0-4667-A9D3-A2B16C66BCD6Q33709965-2698298D-AFD6-4CDA-986F-BA5F69601D04Q33763540-861F859B-B79B-49CB-9267-345256A9A0C4Q33844564-59D892A8-5CD6-4C42-A0B6-2251EACAEAA3Q37272833-2B60ABD0-C940-4D99-BD1F-2257985775E7Q38661081-71374AB7-DDBF-4BFB-A0BD-B95CD514B46AQ38746546-B02B43BB-A574-427D-82B0-B3D4380DC73DQ38776411-46E70818-5BD7-4CB1-940B-57585A93F761Q38776735-5F2B8536-3733-43A3-AC31-FA5DBC6AE2B6Q39147308-37F67645-DC49-46F7-82E0-739209289302Q39167413-3B7F2AB4-5C68-48CA-87A1-891FE3006F36Q45066722-BF4EAC20-1B21-4992-8081-9BD049A56ED4Q46087686-5F047B17-1B73-4366-AE9B-E83175EA9350Q46192546-7681E35D-C789-4504-AC9B-ED989A1AB424Q47103181-9168441E-B333-4EF8-AA31-3883DB198053Q47107479-DE87D97C-5B9B-48E2-A642-6FC3D9F801F7Q47556044-6637757F-8F2F-4865-9CC8-83895B12B926Q49178298-456FFD36-406B-41BA-8F41-F22C30F09853Q49627919-5F5D9B52-CE1E-4683-9FE7-D16CDC9697F7Q50047686-0B403A23-D109-4B9D-BD1F-B12F930433B1Q52654643-F7CD2CF1-50A0-44C1-A1B7-614508CE3B35Q53099936-85607243-5CC0-4A0C-AD92-11BEAD364CEEQ55008806-273E0619-B7C3-4BCD-BC2A-548EBDD0CA35Q55260939-900C5083-F568-4D19-93D2-3E373209DE69Q55523920-5C8BBE9B-1F37-43F9-82B7-7D97AA9CE6F9Q57073983-4C81F8A6-FF64-477F-B153-0C8ACE14B3C8Q57261202-3DA7FD13-5D1E-4094-96C2-3625D8E3F511Q58554189-AC14A57A-E4C3-472F-BDD8-49DCF18C5F91Q58565330-20121F93-0C84-4BD4-A86C-30316B4FCF3EQ58804371-71020F29-5FF4-4EA9-A96C-A32A0BED25B6
P2860
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Forty-Year Trends in Cholangio ...... rahepatic Disease on the Rise.
@en
type
label
Forty-Year Trends in Cholangio ...... rahepatic Disease on the Rise.
@en
prefLabel
Forty-Year Trends in Cholangio ...... rahepatic Disease on the Rise.
@en
P2093
P2860
P1433
P1476
Forty-Year Trends in Cholangio ...... rahepatic Disease on the Rise.
@en
P2093
Andrew X Zhu
Gabriel A Brooks
Supriya K Saha
P2860
P304
P356
10.1634/THEONCOLOGIST.2015-0446
P577
2016-03-21T00:00:00Z